These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19608687)

  • 1. First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis.
    de Vooght KM; van Solinge WW; van Wesel AC; Kersting S; van Wijk R
    Haematologica; 2009 Sep; 94(9):1203-10. PubMed ID: 19608687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia.
    van Wijk R; Rijksen G; Huizinga EG; Nieuwenhuis HK; van Solinge WW
    Blood; 2003 Jan; 101(1):345-7. PubMed ID: 12393545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of six new cases of red blood cell hexokinase deficiency yields four novel mutations in HK1.
    Koralkova P; Mojzikova R; van Oirschot B; Macartney C; Timr P; Vives Corrons JL; Striezencova Laluhova Z; Lejhancova K; Divoky V; van Wijk R
    Blood Cells Mol Dis; 2016 Jul; 59():71-6. PubMed ID: 27282571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human HKR isozyme: organization of the hexokinase I gene, the erythroid-specific promoter, and transcription initiation site.
    Murakami K; Kanno H; Miwa S; Piomelli S
    Mol Genet Metab; 1999 Jun; 67(2):118-30. PubMed ID: 10356311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency.
    van Wijk R; van Solinge WW; Nerlov C; Beutler E; Gelbart T; Rijksen G; Nielsen FC
    Blood; 2003 Feb; 101(4):1596-602. PubMed ID: 12393511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.
    Ukonmaanaho EM; Dell'Anna S; Hakonen A; Wartiovaara-Kautto U; Kakko S; Rab MAE; van Oirschot B; Kraatari-Tiri M; van Wijk R; Rahikkala E
    Br J Haematol; 2024 May; 204(5):2040-2048. PubMed ID: 38415930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression and biological significance of hexokinase in erythroid cells.
    Murakami K; Kanno H; Tancabelic J; Fujii H
    Acta Haematol; 2002; 108(4):204-9. PubMed ID: 12432216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate kinase regulatory element 1 (PKR-RE1) mediates hexokinase gene expression in K562 cells.
    de Vooght KM; van Wijk R; van Oirschot BA; Rijksen G; van Solinge WW
    Blood Cells Mol Dis; 2005; 34(2):186-90. PubMed ID: 15727904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexokinase: gene structure and mutations.
    Kanno H
    Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):83-8. PubMed ID: 10916679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequences downstream of the erythroid promoter are required for high level expression of the human alpha-spectrin gene.
    Wong EY; Lin J; Forget BG; Bodine DM; Gallagher PG
    J Biol Chem; 2004 Dec; 279(53):55024-33. PubMed ID: 15456760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downeast anemia (dea), a new mouse model of severe nonspherocytic hemolytic anemia caused by hexokinase (HK(1)) deficiency.
    Peters LL; Lane PW; Andersen SG; Gwynn B; Barker JE; Beutler E
    Blood Cells Mol Dis; 2001; 27(5):850-60. PubMed ID: 11783948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exonic missense mutation c.28G>A is associated with weak B blood group by affecting RNA splicing of the ABO gene.
    Cai X; Qian C; Wu W; Lei H; Ding Q; Zou W; Xiang D; Wang X
    Transfusion; 2017 Sep; 57(9):2140-2149. PubMed ID: 28653406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the cDNA for human red blood cell-specific hexokinase isozyme.
    Murakami K; Piomelli S
    Blood; 1997 Feb; 89(3):762-6. PubMed ID: 9028305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.
    Solis C; Aizencang GI; Astrin KH; Bishop DF; Desnick RJ
    J Clin Invest; 2001 Mar; 107(6):753-62. PubMed ID: 11254675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human red blood cell loading with hexokinase-inactivating antibodies. An in vitro model for enzyme deficiencies.
    Magnani M; Rossi L; Bianchi M; Serafini G; Stocchi V
    Acta Haematol; 1989; 82(1):27-34. PubMed ID: 2505471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification, and characterization of a recombinant erythroid-specific hexokinase isozyme.
    Bianchi M; Serafini G; Bartolucci E; Palma F; Magnani M
    Blood Cells Mol Dis; 1998 Dec; 24(4):401-11. PubMed ID: 9851893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pathogenic variant c.2714C>A (p. Thr905Lys) in the
    Dongerdiye R; Jagadeesh S; Suresh B; Rajendran A; Devendra R; Warang P; Kedar PS
    J Clin Pathol; 2021 Oct; 74(10):620-624. PubMed ID: 33361148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spermatogenic cell-specific type 1 hexokinase is the predominant hexokinase in sperm.
    Nakamura N; Shibata H; O'Brien DA; Mori C; Eddy EM
    Mol Reprod Dev; 2008 Apr; 75(4):632-40. PubMed ID: 17924400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexokinase deficiency in erythrocytes: a new variant in 5 members of a Finnish family.
    Siimes MA; Rahiala EL; Leisti J
    Scand J Haematol; 1979 Mar; 22(3):214-8. PubMed ID: 451452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
    Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
    Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.